— Know what they know.
Not Investment Advice

VCEL NASDAQ

Vericel Corporation
1W: +1.1% 1M: -1.8% 3M: -13.8% YTD: +12.8% 1Y: +29.9% 3Y: +13.0% 5Y: -18.4%
$40.15
+0.71 (+1.80%)
 
Weekly Expected Move ±4.0%
$37 $39 $40 $42 $43
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $2.1B mcap · 51M float · 1.10% daily turnover · Short 64% of daily vol

📊 Key Metrics

TTM
$306M
Revenue
+23.0% YoY
$24M
Net Income
+240.8% YoY
$50M
Free Cash Flow
-22.7% YoY
72.8%
Gross Margin
0.6%
Op. Margin
2.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE7.2%
ROA5.2%
ROIC5.9%

Valuation

P/E83.6
P/B5.5
EV/EBITDA57.1

Leverage

Debt/Equity0.25
Current Ratio5.04
Interest Cov.40.2x

Quality Scores

Piotroski F7/9
Altman Z10.46
Beneish M-2.62

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms